WAI CHUN BIOTEC Reports Interim Results, Narrowing Losses by Over Half

Stock News

Feb 27

WAI CHUN BIOTEC (00660) announced its interim results for the six months ended December 31, 2025. The company recorded revenue of HK$352 million, representing an increase of 118.65% compared to the same period last year. The loss attributable to company owners was HK$5.939 million, a decrease of 56.53% year-on-year. The loss per share was HK3.33 cents. The increase in revenue was attributed to heightened market consumption and demand during the period. For the six months ended December 31, 2025, the Group achieved a gross profit and gross profit margin of approximately HK$35.7 million and 10.1%, respectively. This compares to a gross profit of approximately HK$21.1 million and a gross profit margin of about 13.1% for the six months ended December 31, 2024. This represents an increase in gross profit of approximately HK$14.5 million, while the gross profit margin decreased by 3.0 percentage points.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1137596426"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137596426\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137596426?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137596426","market":"hk","top_or_hot":-1,"title":"WAI CHUN BIOTEC Reports Interim Results, Narrowing Losses by Over Half","media":"Stock News","content":"<p>WAI CHUN BIOTEC (00660) announced its interim results for the six months ended December 31, 2025. The company recorded revenue of HK$352 million, representing an increase of 118.65% compared to the same period last year. The loss attributable to company owners was HK$5.939 million, a decrease of 56.53% year-on-year. The loss per share was HK3.33 cents. The increase in revenue was attributed to heightened market consumption and demand during the period. For the six months ended December 31, 2025, the Group achieved a gross profit and gross profit margin of approximately HK$35.7 million and 10.1%, respectively. This compares to a gross profit of approximately HK$21.1 million and a gross profit margin of about 13.1% for the six months ended December 31, 2024. This represents an increase in gross profit of approximately HK$14.5 million, while the gross profit margin decreased by 3.0 percentage points.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WAI CHUN BIOTEC Reports Interim Results, Narrowing Losses by Over Half</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWAI CHUN BIOTEC Reports Interim Results, Narrowing Losses by Over Half\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-27 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WAI CHUN BIOTEC (00660) announced its interim results for the six months ended December 31, 2025. The company recorded revenue of HK$352 million, representing an increase of 118.65% compared to the same period last year. The loss attributable to company owners was HK$5.939 million, a decrease of 56.53% year-on-year. The loss per share was HK3.33 cents. The increase in revenue was attributed to heightened market consumption and demand during the period. For the six months ended December 31, 2025, the Group achieved a gross profit and gross profit margin of approximately HK$35.7 million and 10.1%, respectively. This compares to a gross profit of approximately HK$21.1 million and a gross profit margin of about 13.1% for the six months ended December 31, 2024. This represents an increase in gross profit of approximately HK$14.5 million, while the gross profit margin decreased by 3.0 percentage points.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1237","symbol_name":"包装食品与肉类","start_time":0,"source_url":"","article_id":"1137596426","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137596426","pubTimestamp":1772187989,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"WAI CHUN BIOTEC (00660) announced its interim results for the six months ended December 31, 2025. The company recorded revenue of HK$352 million, representing an increase of 118.65% compared to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1237":"包装食品与肉类","00660":"玮俊生物科技"},"translate_title":"伟俊生物公布中期业绩亏损收窄过半","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00660":1},"content_text":"WAI CHUN BIOTEC (00660) announced its interim results for the six months ended December 31, 2025. The company recorded revenue of HK$352 million, representing an increase of 118.65% compared to the same period last year. The loss attributable to company owners was HK$5.939 million, a decrease of 56.53% year-on-year. The loss per share was HK3.33 cents. The increase in revenue was attributed to heightened market consumption and demand during the period. For the six months ended December 31, 2025, the Group achieved a gross profit and gross profit margin of approximately HK$35.7 million and 10.1%, respectively. This compares to a gross profit of approximately HK$21.1 million and a gross profit margin of about 13.1% for the six months ended December 31, 2024. This represents an increase in gross profit of approximately HK$14.5 million, while the gross profit margin decreased by 3.0 percentage points.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}